Literature DB >> 7814553

Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae.

K K Krisher1, A Linscott.   

Abstract

The performances of three commercial broth microdilution MIC assays adapted for use with fastidious organisms--the E test (ET), Fastidious Antimicrobial Susceptibility panel (FAS), and FOX Fastidious panel (FOX)--were compared with a MIC using Mueller-Hinton broth with 5% lysed horse blood (MHLHB) to confirm penicillin and cephalosporin resistance in clinical isolates of Streptococcus pneumoniae. Of the isolates screened for penicillin resistance, 5 (12.8%) were categorized as susceptible, 16 (41.0%) were categorized as intermediate, and 18 (46.2%) were categorized as resistant by MHLHB. Only the isolates exhibiting intermediate-to-resistant MICs were included in the comparison. Agreement within +/- 1 log2 dilution was found in 91, 21, and 76% of the ET, FAS, and FOX MICs, respectively, compared with the MHLHB MIC. No very major or major discrepancies occurred with the ET or FOX; however, two very major interpretive errors occurred with the FAS. Agreement between the ET and MHLHB for cefotaxime, ceftriaxone, and cefuroxime was 88, 85, and 100%, respectively. Less than 50% of cephalosporin MICs categorized as > 0.5 microgram/ml by MHLHB were detected by FAS or FOX. Of the methods compared, the ET was the most reliable alternative for susceptibility testing of pneumococci.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814553      PMCID: PMC263975          DOI: 10.1128/jcm.32.9.2242-2245.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.

Authors:  J H Jorgensen; G V Doern; M J Ferraro; C C Knapp; J M Swenson; J A Washington
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 3.  Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.

Authors:  M R Jacobs
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

4.  Screening pneumococci for penicillin resistance.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  Use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 6.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

7.  Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.

Authors:  I R Friedland; S Shelton; M Paris; S Rinderknecht; S Ehrett; K Krisher; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1993-03       Impact factor: 2.129

8.  Special topics in antimicrobial susceptibility testing: test accuracy against methicillin-resistant Staphylococcus aureus, pneumococci, and the sensitivity of beta-lactamase methods.

Authors:  R N Jones; D C Edson
Journal:  Am J Clin Pathol       Date:  1983-10       Impact factor: 2.493

9.  Evaluation of the E test by using selected gram-positive bacteria.

Authors:  J H Ngui-Yen; E A Bryce; C Porter; J A Smith
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test.

Authors:  J H Jorgensen; A W Howell; L A Maher
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  7 in total

1.  Failure of pristinamycin treatment in a case of pneumococcal pneumonia.

Authors:  C Burucoa; T Pasdeloup; C Chapon; J L Fauchère; R Robert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

Review 2.  Recent advances: medical microbiology.

Authors:  H Richardson; F Smaill
Journal:  BMJ       Date:  1998-10-17

3.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Authors:  F C Tenover; C N Baker; J M Swenson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.

Authors:  M Skulnick; G W Small; P Lo; M P Patel; C R Porter; D E Low; S Matsumura; T Mazzulli
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 5.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

6.  Evaluation of penicillin susceptibility in clinical isolates of Streptococcus pneumoniae oxacillin resistant.

Authors:  A Mosca; R Del Prete; M D'Alagni; R Bilancia; G Miragliotta
Journal:  Eur J Epidemiol       Date:  1996-12       Impact factor: 8.082

7.  Detection of penicillin-resistant Streptococcus pneumoniae with commercially available broth microdilution panels.

Authors:  F S Nolte; B Metchock; T Williams; L Diem; A Bressler; F C Tenover
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.